Short-term outcomes of inner branches for endovascular repair of complex abdominal and thoracoabdominal aortic aneurysms.


Journal

Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 10 12 2020
medline: 26 11 2021
entrez: 9 12 2020
Statut: ppublish

Résumé

To report our early experience using endografts with inner branches for the treatment of complex abdominal aortic aneurysms and thoracoabdominal aortic aneurysms (TAAAs). A retrospective analysis of all patients treated in our institution for complex abdominal aortic aneurysms and TAAAs with custom-made stent grafts consisting of one or more inner branches. Data collected included patients demographics, aortic aneurysm morphology, stent grafts features, perioperative morbidity and mortality and short-term reintervention and mortality rates. Twenty-seven patients (18 males, mean age 70 ± 7.1) were included. Indications for surgery included TAAAs (12, 41%) juxtarenal abdominal aortic aneurysms (10, 37%), type 1A endoleaks (4, 15%) and paraanastamotic aneurysms (1, 4%). A total of 90 inner branches were used. Twenty-one (78%) of the stent grafts consisted only of inner branches and six (22%) had a combination of inner branches with either fenestrations or outer branches. Technical success was achieved in 26/27 (96%) of the patients. There was one perioperative mortality. Six patients suffered from major perioperative adverse events. Mean follow-up was seven months (range 1-23). During the follow-up period, four patients (15%) required reinterventions. Branch-related reinterventions were performed in two (7%) patients. No occlusions of inner branches occurred during the follow-up. Inner branches in branched endovascular aneurysm repairs offer a feasible option for the treatment of complex abdominal aortic aneurysms and TAAAs. The procedures can be completed with high technical success and with acceptable short-term branch-related reintervention rates. Further follow-up is required to determine the long-term durability of this technology.

Identifiants

pubmed: 33292087
doi: 10.1177/1708538120977279
pmc: PMC8564222
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

644-651

Références

J Vasc Surg. 2014 Dec;60(6):1420-8.e1-5
pubmed: 25195145
Eur J Vasc Endovasc Surg. 2018 May;55(5):640-646
pubmed: 29545020
J Cardiovasc Surg (Torino). 2005 Apr;46(2):131-40
pubmed: 15793492
Eur J Vasc Endovasc Surg. 2016 Aug;52(2):141-8
pubmed: 27105550
J Cardiovasc Surg (Torino). 2020 Feb;61(1):2-9
pubmed: 31833736
J Vasc Surg. 2016 Apr;63(4):930-42
pubmed: 26792544
J Vasc Surg. 2019 Apr;69(4):977-985.e1
pubmed: 30477941
J Vasc Surg. 2017 Oct;66(4):982-990
pubmed: 28559176
J Vasc Surg. 2017 Sep;66(3):687-694
pubmed: 28259577
Ann Vasc Surg. 2020 Jul;66:142-151
pubmed: 31669479
J Vasc Surg. 2020 Sep;72(3):866-872
pubmed: 32081475
J Vasc Surg. 2020 Aug;72(2):445-455
pubmed: 31980247
J Vasc Surg. 2017 May;65(5):1249-1259.e10
pubmed: 27986479
Ann Vasc Surg. 2020 Jan;62:213-222
pubmed: 31382008
Eur J Vasc Endovasc Surg. 2016 Mar;51(3):380-5
pubmed: 26818022
J Vasc Surg. 2017 Aug;66(2):354-359
pubmed: 28216359
Eur J Vasc Endovasc Surg. 2015 May;49(5):524-31
pubmed: 25599593
J Vasc Surg. 2002 May;35(5):1048-60
pubmed: 12021727
J Vasc Surg. 2019 Nov;70(5):1409-1418.e3
pubmed: 31255472

Auteurs

Daniel Silverberg (D)

Department of Vascular Surgery, Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv, Israel.

Avner Bar-Dayan (A)

Department of Vascular Surgery, Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv, Israel.

Haitam Hater (H)

Department of Vascular Surgery, Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv, Israel.

Boris Khaitovich (B)

Division of Interventional Radiology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Moshe Halak (M)

Department of Vascular Surgery, Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH